Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it appointed two new members to its board of directors. Thomas Forest Farb-Horch and Agnieszka Winkler joined Dublin, Ohio-based Navidea’s board, effective Oct. 7, each with a three-year term ending concurrently with the company’s 2024 annual stockholders meeting. According to a news release, Farb-Horch, a veteran of over three […]
Personnel
Navidea Biopharmaceuticals makes board of directors changes
Navidea Biopharmaceuticals (NYSE:NAVB) announced today that it made a number of changes on its board of directors. Dublin, Ohio–based Navidea ‘s chair of the board and director S. Kathryn Rouan, along with director Claudine Bruck, retired from those positions, effective immediately. The board appointed Alexander L. Cappello and John K. Scott, Jr., both existing members […]
Lyra Therapeutics appoints new CFO
Lyra Therapeutics (NSDQ:LYRA) announced today that it appointed Jason Cavalier as its new chief financial officer, effective today. Cavalier succeeds the company’s current CFO, Don Elsey, who is retiring while he remains expected to serve in an advisory role to assist with the transition. Watertown, Massachusetts-based Lyra — which develops the XTreo platform designed to […]
Eli Lilly forms neuroscience and immunology units amid leadership changes
Eli Lilly (NYSE:LLY) today announced executive leadership changes as it creates neuroscience and immunology business units. Indianapolis-based Eli Lilly split its bio-medicines segment into Lilly Neuroscience and Lilly Immunology in the organizational shift, to be made effective Sept. 5, with Anne White set to lead the neuroscience unit and Patrik Jonsson set to head up […]
Glytec appoints chief medical officer
Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer. Messler’s responsibilities as the company’s CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development. Additionally, Messler will be supporting the delivery, customer, quality and regulatory teams to ensure ethical and safe glycemic management […]
BD announces two new directors for diabetes spinoff
BD (NYSE:BDX) announced today that it appointed David F. Melcher and Dr. Claire Pomeroy as directors of its diabetes spinoff. Franklin Lakes, N.J.-based BD previously announced the separation of its diabetes care business into an independent, publicly traded company called NewCo. According to a news release, the appointments of Melcher as non-executive chair of the […]
Thermo Fisher Scientific expands corporate leadership team
Thermo Fisher Scientific (NYSE:TMO) announced today that it appointed Dr. Alan Sachs to chief medical officer and Karen E. Nelson to chief scientific officer. Sachs served as Waltham, Mass.-based Thermo Fisher’s CSO since 2016 and will be succeeded by Nelson as he assumes the newly established CMO position at the company. Both will join the […]
Soleo Health appoints new VP of business development, industry relations
Soleo Health announced today that it appointed Becky Rand as its VP of business development and industry relations. Rand’s responsibilities include initiating and maintaining relationships with pharmaceutical manufacturers and biotechnology companies while also looking to broaden the company’s portfolio of exclusive and limited drug distribution partnerships and other strategic initiatives. Frisco, Texas-based Soleo Health is […]
Glytec names Nausheen Moulana as chief technology officer
Cloud-based insulin management software developer Glytec announced today that it appointed Nausheen Moulana as its chief technology officer. In the role of CTO, Moulana will be responsible for Glytec’s product and technology vision, strategy and execution. She will lead the company’s product development teams — focusing on enhancements in provider workflows, electronic health record (EHR) […]
Carbon Health acquires Steady Health and its diabetes platform
Carbon Health announced today that it acquired Steady Health and its platform for using continuous glucose monitoring to personalize diabetes care. San Francisco–based Carbon Health said in a news release that the acquisition accelerates its rollout of a new primary care model designed to integrate its clinic footprint with virtual and hardware-enabled capabilities to create […]
